Meridian Bioscience Inc (VIVO)

Meridian Bioscience, Inc. operates as a life science company that develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases and elevated blood lead levels. The company operates through diagnostics and life science segments. The Diagnostics segment offers testing platforms that include real-time PCR amplification under the Revogene brand; isothermal DNA amplification under the Alethia brand; lateral flow immunoassay using fluorescent chemistry under the Curian brand; rapid immunoassay under the ImmunoCard and ImmunoCard STAT! brands; enzyme-linked immunoassays under the PREMIER brand; anodic stripping voltammetry under the LeadCare brands; and urea breath testing for H. pylori under the BreathID and BreathTek brands. This segment also offers respiratory illness assays, such as tests for Group A strep, mycoplasma pneumonia, influenza, and pertussis, and blood chemistry products for LeadCare test kits for the detection of lead in blood. It sells products through a direct sales force and independent distributors to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices, diagnostics manufacturers, and biotech companies. The Life Science segment offers antigens, antibodies, PCR/qPCR reagents, isothermal reagents, nucleotides, and bioresearch reagents used by in vitro diagnostic manufacturers as well as researchers in immunological and molecular tests for human, animal, plant, and environmental applications. Meridian Bioscience, Inc. was formerly known as Meridian Diagnostics, Inc. and changed its name to Meridian Bioscience, Inc. in January 2001. Meridian Bioscience, Inc. was incorporated in 1976 and is based in Cincinnati, Ohio with additional offices in Memphis, Tennessee; Quebec, Canada; Beijing, China; Luckenwalde, Germany; Modiin, Israel; Milan, Italy; and London, United Kingdom. The company operates as a subsidiary of SD Biosensor, Inc.